collection
https://read.qxmd.com/read/28702763/pharmacokinetics-of-antifungal-drugs-practical-implications-for-optimized-treatment-of-patients
#21
REVIEW
Romuald Bellmann, Piotr Smuszkiewicz
INTRODUCTION: Because of the high mortality of invasive fungal infections (IFIs), appropriate exposure to antifungals appears to be crucial for therapeutic efficacy and safety. MATERIALS AND METHODS: This review summarises published pharmacokinetic data on systemically administered antifungals focusing on co-morbidities, target-site penetration, and combination antifungal therapy. CONCLUSIONS AND DISCUSSION: Amphotericin B is eliminated unchanged via urine and faeces...
December 2017: Infection
https://read.qxmd.com/read/29069564/a-crispr-way-to-diagnose-infectious-diseases
#22
JOURNAL ARTICLE
Angela M Caliendo, Richard L Hodinka
New England Journal of Medicine, Volume 377, Issue 17, Page 1685-1687, October 2017.
October 26, 2017: New England Journal of Medicine
https://read.qxmd.com/read/29097436/copd-algorithms-and-clinical-management
#23
EDITORIAL
Rosa Faner, Alvar Agustí
No abstract text is available yet for this article.
November 2017: European Respiratory Journal
https://read.qxmd.com/read/29053792/2017-infectious-diseases-society-of-america-clinical-practice-guidelines-for-the-diagnosis-and-management-of-infectious-diarrhea
#24
JOURNAL ARTICLE
Andi L Shane, Rajal K Mody, John A Crump, Phillip I Tarr, Theodore S Steiner, Karen Kotloff, Joanne M Langley, Christine Wanke, Cirle Alcantara Warren, Allen C Cheng, Joseph Cantey, Larry K Pickering
These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea. They are not intended to replace physician judgement regarding specific patients or clinical or public health situations. This document does not provide detailed recommendations on infection prevention and control aspects related to infectious diarrhea.
November 29, 2017: Clinical Infectious Diseases
https://read.qxmd.com/read/27011791/sepsis-induced-myocardial-dysfunction-pathophysiology-and-management
#25
REVIEW
Yasuyuki Kakihana, Takashi Ito, Mayumi Nakahara, Keiji Yamaguchi, Tomotsugu Yasuda
Sepsis is aggravated by an inappropriate immune response to invading microorganisms, which occasionally leads to multiple organ failure. Several lines of evidence suggest that the ventricular myocardium is depressed during sepsis with features of diastolic dysfunction. Potential candidates responsible for septic cardiomyopathy include pathogen-associated molecular patterns (PAMPs), cytokines, and nitric oxide. Extracellular histones and high-mobility group box 1 that function as endogenous damage-associated molecular patterns (DAMPs) also contribute to the myocardial dysfunction associated with sepsis...
2016: Journal of Intensive Care
https://read.qxmd.com/read/26761185/zika-virus-in-the-americas-yet-another-arbovirus-threat
#26
JOURNAL ARTICLE
Anthony S Fauci, David M Morens
The explosive pandemic of Zika virus infection occurring throughout South America, Central America, and the Caribbean (see map) and potentially threatening the United States is the most recent of four unexpected arrivals of important arthropod-borne viral diseases in the Western Hemisphere over the..
February 18, 2016: New England Journal of Medicine
https://read.qxmd.com/read/26679628/clinical-practice-guideline-for-the-management-of-candidiasis-2016-update-by-the-infectious-diseases-society-of-america
#27
JOURNAL ARTICLE
Peter G Pappas, Carol A Kauffman, David R Andes, Cornelius J Clancy, Kieren A Marr, Luis Ostrosky-Zeichner, Annette C Reboli, Mindy G Schuster, Jose A Vazquez, Thomas J Walsh, Theoklis E Zaoutis, Jack D Sobel
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
February 15, 2016: Clinical Infectious Diseases
https://read.qxmd.com/read/26605929/treatment-of-tuberculosis
#28
REVIEW
C Robert Horsburgh, Clifton E Barry, Christoph Lange
Tuberculosis, a scourge since prehistoric times, affects more than 9 million people and causes the death of 1.5 million people each year. Effective treatment has been available for 60 years, but such treatment takes at least 6 months, and resistance to the drugs, which is increasing throughout the..
November 26, 2015: New England Journal of Medicine
https://read.qxmd.com/read/26461953/in-celebration-of-the-jesuit-s-powder-a-history-of-malaria-treatment
#29
JOURNAL ARTICLE
Natalie Harrison
No abstract text is available yet for this article.
October 2015: Lancet Infectious Diseases
https://read.qxmd.com/read/26444731/invasive-candidiasis
#30
REVIEW
Bart Jan Kullberg, Maiken C Arendrup
No abstract text is available yet for this article.
October 8, 2015: New England Journal of Medicine
https://read.qxmd.com/read/26352817/images-in-clinical-medicine-a-viper-bite
#31
JOURNAL ARTICLE
Tajamul Hussain, Rafi A Jan
A 46-year-old farmer presented to the emergency department 3 hours after his penis was bitten by a snake while he was urinating in an open field. The snake was identified by the patient as "gunas," which is the local name of the Levantine viper (Macrovipera lebetina). Physical examination revealed..
September 10, 2015: New England Journal of Medicine
https://read.qxmd.com/read/26279970/cryptococcal-meningitis-diagnosis-and-management-update
#32
JOURNAL ARTICLE
Mahsa Abassi, David R Boulware, Joshua Rhein
Recent advances in the diagnosis and management of cryptococcal meningitis are promising and have been improving long-term survival. Point of care testing has made diagnosing cryptococcal meningitis rapid, practical, and affordable. Targeted screening and treatment programs for cryptococcal antigenemia are a cost effective method for reducing early mortality on antiretroviral therapy (ART). Optimal initial management with amphotericin and flucytosine improves survival against alternative therapies, although amphotericin is difficult to administer and flucytosine is not available in middle or low income countries, where cryptococcal meningitis is most prevalent...
June 1, 2015: Current Tropical Medicine Reports
https://read.qxmd.com/read/26277247/community-acquired-pneumonia
#33
REVIEW
Elena Prina, Otavio T Ranzani, Antoni Torres
Community-acquired pneumonia causes great mortality and morbidity and high costs worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of patients with pneumonia. To reduce the misuse of antibiotics, antibiotic resistance, and side-effects, an empirical, effective, and individualised antibiotic treatment is needed. Follow-up after the start of antibiotic treatment is also important, and management should include early shifts to oral antibiotics, stewardship according to the microbiological results, and short-duration antibiotic treatment that accounts for the clinical stability criteria...
September 12, 2015: Lancet
https://read.qxmd.com/read/26216176/cdc-updates-guidelines-for-treating-sexually-transmitted-diseases
#34
EDITORIAL
Roberto Romero, Ingrid Nygaard
No abstract text is available yet for this article.
August 2015: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/26198113/tuberculosis-a-disease-without-boundaries
#35
REVIEW
Nicole Fogel
Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (MTB) that usually affects the lungs leading to severe coughing, fever, and chest pains. Although current research in the past four years has provided valuable insight into TB transmission, diagnosis, and treatment, much remains to be discovered to effectively decrease the incidence of and eventually eradicate TB. The disease still puts a strain on public health, being only second to HIV/AIDS in causing high mortality rates. This review will highlight the history of TB as well as provide an overview of the current literature on epidemiology, pathogenesis and the immune response, treatment, and control of TB...
September 2015: Tuberculosis
https://read.qxmd.com/read/26180063/epidemiology-clinical-presentation-laboratory-diagnosis-antimicrobial-resistance-and-antimicrobial-management-of-invasive-salmonella-infections
#36
REVIEW
John A Crump, Maria Sjölund-Karlsson, Melita A Gordon, Christopher M Parry
Salmonella enterica infections are common causes of bloodstream infection in low-resource areas, where they may be difficult to distinguish from other febrile illnesses and may be associated with a high case fatality ratio. Microbiologic culture of blood or bone marrow remains the mainstay of laboratory diagnosis. Antimicrobial resistance has emerged in Salmonella enterica, initially to the traditional first-line drugs chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole. Decreased fluoroquinolone susceptibility and then fluoroquinolone resistance have developed in association with chromosomal mutations in the quinolone resistance-determining region of genes encoding DNA gyrase and topoisomerase IV and also by plasmid-mediated resistance mechanisms...
October 2015: Clinical Microbiology Reviews
https://read.qxmd.com/read/23439232/guidelines-for-diagnosis-treatment-and-prevention-of-clostridium-difficile-infections
#37
REVIEW
Christina M Surawicz, Lawrence J Brandt, David G Binion, Ashwin N Ananthakrishnan, Scott R Curry, Peter H Gilligan, Lynne V McFarland, Mark Mellow, Brian S Zuckerbraun
Clostridium difficile infection (CDI) is a leading cause of hospital-associated gastrointestinal illness and places a high burden on our health-care system. Patients with CDI typically have extended lengths-of-stay in hospitals, and CDI is a frequent cause of large hospital outbreaks of disease. This guideline provides recommendations for the diagnosis and management of patients with CDI as well as for the prevention and control of outbreaks while supplementing previously published guidelines. New molecular diagnostic stool tests will likely replace current enzyme immunoassay tests...
April 2013: American Journal of Gastroenterology
https://read.qxmd.com/read/22219235/skin-and-soft-tissue-infections-classifying-and-treating-a-spectrum
#38
REVIEW
Sabitha Rajan
Skin and soft-tissue infections (SSTIs) are a common presenting problem in both inpatients and outpatients. SSTIs have been broadly classified as complicated or uncomplicated, but specific disease processes and patient characteristics are important in guiding clinical management. Early recognition of the extent of infection, close follow-up, and familiarity with local antibiotic susceptibility data are critical to successful treatment.
January 2012: Cleveland Clinic Journal of Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.